The Effects of a Mineral Supplement (Aquamin $F^{(R)}$) and Its Combination with Multi-Species Lactic Acid Bacteria (LAB) on Bone Accretion in an Ovariectomized Rat Model

  • Received : 2010.08.09
  • Accepted : 2010.12.29
  • Published : 2010.12.31

Abstract

Although an adequete intake of calcium (Ca) is recommended for the treatment and prevention of osteoporosis, the intake of Ca should be restricted because of its low rate of intestinal absorption. The purpose of this experiment was to identity the effect of the combined administration of Aquamin F (AQF) (a calcium agent) and lactic acid bacteria (LAB) on osteoporosis. Thirty ovariectomized (OVX) rats and six control rats were assigned to the following six groups, with six animals per group: sham Ca-deficient diet (Ca-D), OVX, LAB, AQF, and LAB-AQF. During the experiment, the body weight was measured; and after the experiment was completed, the serum biochemical analysis, the alkaline phosphatase, calcium, and inorganic phosphorus leves were measured. The tissue of the femur was stained and then scanned via CT. The body weight of the OVX group increased more significantly than that of the control group. The results of the bone mineral content (BMC), Bone mineral density (BMD), serum biochemical analysis and histological test on the femur epiphysis showed no difference between the OVX group and the LAB group, whereas the results of the AQF group were more significant than those of the OVX group. In particular, the LAB+AQF group showed more significant increases in the aforementioned results than the AQF group. This experiment showed that the combined administration of AQF and LAB in ovariectomized rats more significantly increased bone density than did a single administration of either AQF or LAB.

Keywords

References

  1. Balena R, Toolan BC, Shea M. The effects of 2-year treatment with the aminobis-phosphonate alendronate on bone metabolism, bone histomorphometry, and bone strength in ovariectomized nonhuman primate. J Clin Invest. 1993.92: 2577-2586. https://doi.org/10.1172/JCI116872
  2. Brassart D, Vey E. Patient Cooperation Treaty. 1998: WO99/02170.
  3. Byun JS, Rho SN, Park JS, Park HM. Effect of isoflavone supplementation on bone metabolism in ovariectomized rats at different ages. J Korean Soc Food Sci Nutr. 2005. 34: 1350-1356. https://doi.org/10.3746/jkfn.2005.34.9.1350
  4. Cashman KD. Prebiotics and calcium bioavailability. Curr Issues Intest Microbiol. 2003. 4: 21-32.
  5. Crittenden RG, Martinez NR, Playne MJ. Synthesis and utilisation of folate by yoghurt starter cultures and probiotic bacteria. Int J Food Microbiol. 2003. 80: 217-222. https://doi.org/10.1016/S0168-1605(02)00170-8
  6. Eriksen EF. Normal and pathological remodelling of human trabecular bone: three-dimensional reconstruction of the remodelling sequence in normals and metabolic bone disease. Endocrine Rev. 1986.7: 379-408. https://doi.org/10.1210/edrv-7-4-379
  7. Ettinger MP. Aging bone and osteoporosis: strategies for preventing fractures in the elderly-arch. Intern Med. 2003. 163: 2237-2246. https://doi.org/10.1001/archinte.163.18.2237
  8. Frestedt JL, Kuskowski MA, Zenk JL. A natural seaweed derived mineral supplement (Aquamin F) for knee osteoarthritis: a randomised, placebo controlled pilot study. Nutr J. 2009. 8: 7. https://doi.org/10.1186/1475-2891-8-7
  9. Hancock RD, Viola R. The use of micro-organisms for L-ascorbic acid production: current status and future perspectives. Appl Microbiol Biotechnol. 2001. 56: 567-576. https://doi.org/10.1007/s002530100723
  10. Hill MJ. Intestinal flora and endogenous vitamin synthesis. Eur J Cancer Prev. 1997. 6(Suppl 1): 43-45.
  11. Kalu DN. The ovariectomized rat model of postmenopausal bone loss. Bone Miner Res. 1991. 15: 175-191. https://doi.org/10.1016/0169-6009(91)90124-I
  12. Lee EJ, Lee HM, Parle ES. Perception gap of calcium between postmenopausal women with osteoporosis and physicians. Korean Journal of Bone Metabolism 2009. 16: 53-58.
  13. Lee JW, Kim HJ, Jhee OH, Won HD, Yu YJ, Lee MH. Effects of alternative medicine extract on bone mineral density, bone strength and biochemical markers of bone metabolism in ovariectomized rats. Korean J Food Nut. 2005. 8: 72-80.
  14. Lee YB, Lee HJ, Kim KS, Lee JY, Nam SY, Cheon SH. Evaluation of the preventive effect of isoflavone extract on bone loss in ovariectomized rats. Biosci Biotechnol Biochem. 2004. 68: 1040-1045. https://doi.org/10.1271/bbb.68.1040
  15. Okasaki R, Inoue D, Shibata M, Saika M. Estrogen promotes early osteoblast differentiation and inhibits adipocyte differentiation in mouse bone marrow stroma cell lines that express estrogen receptor (ER) $\alpha$ or $\beta$. Endocrinology 2002. 143: 2349-2356. https://doi.org/10.1210/en.143.6.2349
  16. Pacifici R. Estrogen, cytokines and pathogenesis of postmenopausal osteoporosis. J Bone Mine Res. 1996.8: 1043-1051.
  17. Price PA, Pathermore JG, DOftos LJ. New biochemical marker for bone metabolism. J Clin Invest. 1980.66: 878-883. https://doi.org/10.1172/JCI109954
  18. Ross RK, Pagamm-Hill A, Mark TM, Henderson BE. Cardiovascular benefits of estrogen replacement therapy. Am J Obstet Gynecol. l989. 160: 1301-1306. https://doi.org/10.1016/S0002-9378(89)80017-1
  19. Sarioglu M, Tuzun C, Unlu Z, Tikiz C, Taneli F, Uvanik BS. Comparison of the effect of alendronate and risedronate on bone mineral density and bone and turnover markers in postmenopausal osteoporesis. Rheumatol Int. 2006. 26: 195-200. https://doi.org/10.1007/s00296-004-0544-z
  20. Takano-Yamamoto T, Rodam GA. Direct effects of 17$\beta$-estradiol on trabecular bone in ovarictomized rats. Proc Natl Acad Sci. 1990.87: 2172-2176. https://doi.org/10.1073/pnas.87.6.2172
  21. Turner RT, Vandersteenhoven JJ, Bell NH. The effects of ovariectomy and 17 beta-estradiol on cortical bone histomorphometry in growing rats. J Bone Miner Res. 1987. 2: 115-122.
  22. Villa ML, Marcus R, Ramirez Delay R, Kelsey JL. Factors contributing to skeletal health of postmenopausal mexicanamerican women. J Bone Miner Res. 1995.10: 1233-1242.
  23. Weber P. The role of vitamins in the prevention of osteoporosis-a brief status report. Int J Vitam Nutr Res. 1999. 69: 194-197. https://doi.org/10.1024/0300-9831.69.3.194
  24. Whitney EN, Cataldo CB, Rolfed SR. Osteoporosis and calcium. understanding normal and clinical nutrition. 2002. 6th Ed: 420-423.
  25. Women's Health Initiative Steering Committee. Effects of conjugated equine estrogen in Women's Health Initiative randomized controlled trial. JAMA. 2004 291: 1701-1712. https://doi.org/10.1001/jama.291.14.1701
  26. Wronski TJ, Cintron M, Dann LM. Temporal relationship between bone loss and increased bone turnover in ovariectomized rats. Calcif Tissue Int. 1988.43: 179-183. https://doi.org/10.1007/BF02571317